Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
Posted On: 11/16/2016 1:18:45 PM
Post# of 72447
Avatar
Posted By: sox0407
Signs that CTIX is already working with a potential partner on K.

K-OC was originally planned for a Phase 1b/2 trial in combination with doxorubicin in June. After Dr. B joined the company, now it's planned for a Phase 2a POC trial designed to show the modulation of p53 in tumors, with K for three weeks followed by doxorubicin for four cycles.

This is what management said in the Q&A yesterday.

"It is more prudent for us to take into consideration what a potential partner wants and make that happen."

"Concerning Kevetrin, a successful short trial identifying p53 modulation in the tumor and a successful development of a formulation for frequent dosing is needed."

A K partnership could be sooner than we thought.













(2)
(0)






Dont-give-up.jpg



  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site